Names | |
---|---|
Preferred IUPAC name 2-butanoic acid | |
Other names
2-(3-Butyramido-2,4,6-triiodobenzyl)butanoic acid 2-methyl]butanoic acid | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.043.976 |
EC Number |
|
KEGG | |
MeSH | D014441 |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C15H18I3NO3 |
Molar mass | 641.02 g/mol |
Pharmacology | |
ATC code | V08AC09 (WHO) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). N verify (what is ?) Infobox references |
Tyropanoic acid and its salt sodium tyropanoate are radiocontrast agents used in cholecystography (X-ray diagnosis of gallstones). Trade names include Bilopaque, Lumopaque, Tyropaque, and Bilopac. This molecule contains three heavy iodine atoms which obstruct X-rays in the same way as the calcium in bones to produce a visible image. After injection it is rapidly excreted into the bile.
References
- "PubChem CID 5611".
- Felicetta, James V.; Green, William L.; Nelp, Wil B. (May 1980). "Inhibition of hepatic binding of thyroxine by cholecystographic agents". J. Clin. Invest. 65 (5): 1032–40. doi:10.1172/JCI109755. PMC 371433. PMID 7364937.
Contrast media (V08) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
X-ray and CT |
| ||||||||||||
MRI |
| ||||||||||||
Ultrasound |
| ||||||||||||
|
This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |
This article about an organic halide is a stub. You can help Misplaced Pages by expanding it. |